Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Common Stock | Options Exercise | $1.61M | +38.9K | +62.56% | $41.25 | 101K | Mar 1, 2023 | Direct | |
transaction | HIG | Common Stock | Gift | $0 | -5K | -4.94% | $0.00 | 96.1K | Mar 1, 2023 | Direct | F1 |
transaction | HIG | Common Stock | Sale | -$514K | -6.56K | -6.82% | $78.34 | 89.6K | Mar 1, 2023 | Direct | F2, F3 |
transaction | HIG | Common Stock | Sale | -$2.52M | -32.4K | -36.13% | $77.75 | 57.2K | Mar 1, 2023 | Direct | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HIG | Stock Option | Award | $0 | +57.5K | $0.00 | 57.5K | Feb 28, 2023 | Common Stock | 57.5K | $78.28 | Direct | F5 | |
transaction | HIG | Stock Option | Options Exercise | $0 | -38.9K | -50% | $0.00 | 38.9K | Mar 1, 2023 | Common Stock | 38.9K | $41.25 | Direct | F6 |
holding | HIG | Stock Option | 72.1K | Feb 28, 2023 | Common Stock | 72.1K | $43.59 | Direct | F7 | |||||
holding | HIG | Stock Option | 70.7K | Feb 28, 2023 | Common Stock | 70.7K | $48.89 | Direct | F8 | |||||
holding | HIG | Stock Option | 75.8K | Feb 28, 2023 | Common Stock | 75.8K | $49.01 | Direct | F9 | |||||
holding | HIG | Stock Option | 67.2K | Feb 28, 2023 | Common Stock | 67.2K | $51.87 | Direct | F10 | |||||
holding | HIG | Stock Option | 63.2K | Feb 28, 2023 | Common Stock | 63.2K | $53.81 | Direct | F11 | |||||
holding | HIG | Stock Option | 71.3K | Feb 28, 2023 | Common Stock | 71.3K | $55.27 | Direct | F12 | |||||
holding | HIG | Stock Option | 75.5K | Feb 28, 2023 | Common Stock | 75.5K | $69.41 | Direct | F13 |
Id | Content |
---|---|
F1 | This transaction involved a gift to a charitable donor-advised fund, effected pursuant to a trading plan previously adopted by Ms. Costello on November 2, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
F2 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Costello on November 2, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
F3 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $78.25 - $78.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $77.25 - $78.25 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | One-third of the options will become exercisable on February 28, 2024, an additional one-third of the options will become exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
F6 | The options became fully exercisable on March 3, 2018, the third anniversary of the grant date. |
F7 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
F8 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
F9 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
F10 | One-third of the options became exercisable on February 23, 2022, an additional one-third of the options became exercisable on February 23, 2023 and the remaining one-third of the options will become exercisable on February 23, 2024, the third anniversary of the grant date. |
F11 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
F12 | The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
F13 | One-third of the options became exercisable on February 23, 2023, an additional one-third of the options will become exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date. |